Todays milestone expands the strong clinical profile of Wegovy that includes multiple indications that no other GLP-1 for weight loss can claim. As with other drugs in the same class, Wegovy HD comes with a familiar list of potential side effects including nausea, vomiting, constipation, fatigue, dizziness, headache, sensitivity to touch and hair loss
However, important safety considerations include: Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these medications may be needed) Not recommended in severe gastrointestinal disease, including severe gastroparesis Risk of diabetic retinopathy complications, particularly in patients with pre-existing retinopathy Pancreatitis risk requiring immediate discontinuation if suspected Not recommended during pregnancy or breastfeeding Not sure where to start
The standard dose is 2 mg once weekly, administered on the same day each week regardless of meals
Pivovarova O, Hohn A, Grune T, Pfeiffer AF, Rudovich N
protect the gastrointestinal tract from ulcers and inflammation